WebA separate subgroup analysis in symptomatic patients only again revealed a relatively high summary proportion of false-positive follow-up FDG-PET of 37.5% (random effects). In conclusion, the false-positive proportion of follow-up FDG-PET in lymphoma patients who initially achieved an end-of-treatment complete remission is high and remains high ... WebJun 1, 2024 · Cases of false-positive lymph nodes on PET scans, sometimes leading to unnecessary biopsies, are being reported after COVID-19 vaccination.
PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma
WebDec 8, 2012 · Using this method, the number of false-positive scans was clearly reduced, and the 2-year EFS for patients with a favorable scan were 79% versus 21% for those with an unfavorable scan. 10 However, only 16 of the 92 patients had an unfavorable scan and induction therapy was not standardized, making the interpretation of these results … WebThese abnormal uptakes on the FDG PET/CT scan after vaccination have been described since 2006, initially by Williams et al in a 59-year-old man with large B-cell lymphoma in remission, which showed an increase in uptake in a left axillary lymph node. The patient had been recently immunized, but the time elapsed or the type of vaccine was not ... introit in english
False-Positive Lymph Nodes on PET Scans After COVID …
WebJul 24, 2024 · We describe a case of a 16-year-old female with a false-positive positron emission tomography (PET) scan result following recent COVID-19 vaccination in left deltoid. The patient was treated for Hodgkin lymphoma (nodular sclerosing type), stage IIA bulky disease as per National Comprehensive Cancer Network guidelines, and … WebConclusion: The authors conclude that FDG PET/CT can help exclude persistent and/or recurrent Hodgkin lymphoma after first-line therapy. Because of the false-positive results and the toxicity of salvage chemotherapy, including high-dose chemotherapy with autologous stem cell support, biopsy of the FDG-avid lesion is still needed. WebJul 23, 2015 · Treatment with the monoclonal antibody rituximab as part of the R-CHOP regimen in diffuse large B-cell lymphoma may induce a strong inflammatory “flare” response and is a well-known cause of “false … introit for easter sunday